c-jun N-terminal kinase 1/c-jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver

Molecular and Cellular Biology

Volumn 34, Issue 6, 2014, Pages 1100-1120

  Ferreira, Duarte M S ^a,b   Afonso, Marta B ^a   Rodrigues, Pedro M ^a   Simão, André L ^a   Pereira, Diane M ^a   Borralho, Pedro M ^a   Rodrigues, Cecília M P ^a   Castro, Rui E ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; DEOXYCHOLIC ACID; HEPATOCYTES; LIVER; MALE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 8; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84894244461     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00420-13     Document Type: Article

References (73)

1. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K. 1990. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12:1216-1221. http://dx.doi.org/10.1002/hep.1840120523.
2. Higuchi H, Gores GJ. 2003. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G734-G738. http://dx.doi.org/10.1152/ajpgi.00491.2002.
3. Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. 2004. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J. Biol. Chem. 279:51-60. http://dx.doi.org/10.1074/jbc.M309476200.
4. Gupta S, Natarajan R, Payne SG, Studer EJ, Spiegel S, Dent P, Hylemon PB. 2004. Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation. J. Biol. Chem. 279:5821-5828. http://dx.doi.org/10.1074/jbc.M310979200.
5. Yang JI, Yoon JH, Myung SJ, Gwak GY, Kim W, Chung GE, Lee SH, Lee SM, Kim CY, Lee HS. 2007. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem. Biophys. Res. Commun. 361:156-161. http://dx.doi.org/10.1016/j.bbrc.2007.07.001.
6. Rodrigues CM, Sola S, Sharpe JC, Moura JJ, Steer CJ. 2003. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 42:3070-3080. http://dx.doi.org/10.1021/bi026979d.
7. Castro RE, Amaral JD, Sola S, Kren BT, Steer CJ, Rodrigues CM. 2007. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G327-G334. http://dx.doi.org/10.1152/ajpgi.00093.2007.
8. Yamakuchi M, Ferlito M, Lowenstein CJ. 2008. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105:13421-13426. http://dx.doi.org/10.1073/pnas.0801613105.
9. Brooks CL, Gu W. 2009. How does SIRT1 affect metabolism, senescence and cancer? Nat. Rev. Cancer 9:123-128. http://dx.doi.org/10.1038/nrc2562.
10. Hermeking H. 2010. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17:193-199. http://dx.doi.org/10.1038/cdd.2009.56.
11. Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G. 2010. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol. Pharmacol. 77:1016-1024. http://dx.doi.org/10.1124/mol.109.063321.
12. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. 1998. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 4:165-178.
13. Rodrigues CM, Ma X, Linehan-Stiers C, Fan G, Kren BT, Steer CJ. 1999. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6:842-854. http://dx.doi.org/10.1038/sj.cdd.4400560.
14. Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM. 2013. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J. Hepatol. 58:119-125. http://dx.doi.org/10.1016/j.jhep.2012.08.008.
15. Aranha MM, Cortez-Pinto H, Costa A, da Silva IB, Camilo ME, de Moura MC, Rodrigues CM. 2008. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur. J. Gastroenterol. Hepatol. 20:519-525. http://dx.doi.org/10.1097/MEG.0b013e3282f4710a.
16. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499:97-101. http://dx.doi.org/10.1038/nature12347.
17. Rodrigues CM, Kren BT, Steer CJ, Setchell KD. 1995. The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. Gastroenterology 109:1835-1844. http://dx.doi.org/10.1016/0016-5085(95)90750-5.
18. Kren BT, Rodrigues CM, Setchell KD, Steer CJ. 2001. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding. Liver Transpl. 7:321-334. http://dx.doi.org/10.1053/jlts.2001.23062.
19. Mariash CN, Seelig S, Schwartz HL, Oppenheimer JH. 1986. Rapid synergistic interaction between thyroid hormone and carbohydrate on mRNAS14 induction. J. Biol. Chem. 261:9583-9586.
20. Castro RE, Ferreira DM, Zhang X, Borralho PM, Sarver AL, Zeng Y, Steer CJ, Kren BT, Rodrigues CM. 2010. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G887-G897. http://dx.doi.org/10.1152/ajpgi.00216.2010.
21. Park JS, Surendran S, Kamendulis LM, Morral N. 2011. Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies. BMC Res. Notes 4:8. http://dx.doi.org/10.1186/1756-0500-4-8.
22. Xiong S, Salazar G, Patrushev N, Alexander RW. 2011. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 286:5289-5299. http://dx.doi.org/10.1074/jbc.M110.163667.
23. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134. http://dx.doi.org/10.1038/nature05939.
24. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915. http://dx.doi.org/10.1126/science.2144057.
25. Wang Y, Luo W, Reiser G. 2007. Proteinase-activated receptor-1 and-2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. Biochem. J. 401:65-78. http://dx.doi.org/10.1042/BJ20060732.
26. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696. http://dx.doi.org/10.1126/science.277.5326.693.
27. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939. http://dx.doi.org/10.1016/0896-6273(95)90331-3.
28. Kim SW, Li Z, Moore PS, Monaghan AP, Chang Y, Nichols M, John B. 2010. A sensitive non-radioactive northern blot method to detect small RNAs. Nucleic Acids Res. 38:e98. http://dx.doi.org/10.1093/nar/gkp1235.
29. Yamakuchi M, Lowenstein CJ. 2009. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8:712-715. http://dx.doi.org/10.4161/cc.8.5.7753.
30. Zhu H, Yang Y, Wang Y, Li J, Schiller PW, Peng T. 2011. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by downregulating Sirt1. Cardiovasc. Res. 92:75-84. http://dx.doi.org/10.1093/cvr/cvr145.
31. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. 2011. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J. Biol. Chem. 286:25992-26002. http://dx.doi.org/10.1074/jbc.M111.229401.
32. Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. 2012. MiR-122 in hepatic function and liver diseases. Protein Cell 3:364-371. http://dx.doi.org/10.1007/s13238-012-2036-3.
33. Fernandez-Hernando C, Ramirez CM, Goedeke L, Suarez Y. 2013. MicroRNAs in metabolic disease. Arterioscler. Thromb. Vasc. Biol. 33:178-185. http://dx.doi.org/10.1161/ATVBAHA.112.300144.
34. Fukuhara T, Matsuura Y. 2013. Role of miR-122 and lipid metabolism in HCV infection. J. Gastroenterol. 48:169-176. http://dx.doi.org/10.1007/s00535-012-0661-5.
35. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K. 2012. Essential metabolic, antiinflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122:2871-2883. http://dx.doi.org/10.1172/JCI63539.
36. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP. 2012. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122:2884-2897. http://dx.doi.org/10.1172/JCI63455.
37. Jordan SD, Kruger M, Willmes DM, Redemann N, Wunderlich FT, Bronneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Bottger T, Braun T, Seibler J, Bruning JC. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13:434-446. http://dx.doi.org/10.1038/ncb2211.
38. Kren BT, Rodrigues CM, Setchell KD, Steer CJ. 1995. Posttranscriptional regulation of mRNA levels in rat liver associated with deoxycholic acid feeding. Am. J. Physiol. 269:G961-G973.
39. Ignacio Barrasa J, Olmo N, Perez-Ramos P, Santiago-Gomez A, Lecona E, Turnay J, Antonia Lizarbe M. 2011. Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells. Apoptosis 16:1054-1067. http://dx.doi.org/10.1007/s10495-011-0633-x.
40. Poulsen MM, Jorgensen JO, Jessen N, Richelsen B, Pedersen SB. 2013. Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann. N. Y. Acad. Sci. 1290:74-82. http://dx.doi.org/10.1111/nyas.12141.
41. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Treguer K, Carmona G, Bonauer A, Horrevoets AJ, Didier N, Girmatsion Z, Biliczki P, Ehrlich JR, Katus HA, Muller OJ, Potente M, Zeiher AM, Hermeking H, Dimmeler S. 2013. MicroRNA-34a regulates cardiac ageing and function. Nature 495:107-110. http://dx.doi.org/10.1038/nature11919.
42. Concepcion CP, Han YC, Mu P, Bonetti C, Yao E, D'Andrea A, Vidigal JA, Maughan WP, Ogrodowski P, Ventura A. 2012. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8:e1002797. http://dx.doi.org/10.1371/journal.pgen.1002797.
43. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, Amorino G, Valerie K, Sealy L, Engelhardt JF, Grant S, Hylemon PB, Dent P. 2003. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol. Cell. Biol. 23:3052-3066. http://dx.doi.org/10.1128/MCB.23.9.3052-3066.2003.
44. Fuchs SY, Adler V, Pincus MR, Ronai Z. 1998. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. U. S. A. 95:10541-10546. http://dx.doi.org/10.1073/pnas.95.18.10541.
45. Ljungman M. 2000. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2:208-225. http://dx.doi.org/10.1038/sj.neo.7900073.
46. Ferreira DM, Castro RE, Machado MV, Evangelista T, Silvestre A, Costa A, Coutinho J, Carepa F, Cortez-Pinto H, Rodrigues CM. 2011. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia 54:1788-1798. http://dx.doi.org/10.1007/s00125-011-2130-8.
47. Amir M, Liu K, Zhao E, Czaja MJ. 2012. Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death. J. Cell. Biochem. 113:3254-3265. http://dx.doi.org/10.1002/jcb.24203.
48. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, Brenner DA. 2003. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37:824-832. http://dx.doi.org/10.1053/jhep.2003.50135.
49. Sabapathy K, Wagner EF. 2004. JNK2: a negative regulator of cellular proliferation. Cell Cycle 3:1520-1523. http://dx.doi.org/10.4161/cc.3.12.1315.
50. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:2760-2770.
51. Saha MN, Jiang H, Yang Y, Zhu X, Wang X, Schimmer AD, Qiu L, Chang H. 2012. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma. PLoS One 7:e30215. http://dx.doi.org/10.1371/journal.pone.0030215.
52. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. 2005. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 589:47-65. http://dx.doi.org/10.1016/j.mrrev.2004.08.001.
53. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. 1998. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101:2790-2799. http://dx.doi.org/10.1172/JCI1325.
54. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26:745-752. http://dx.doi.org/10.1016/j.molcel.2007.05.010.
55. Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, Dent P. 2001. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCAinduced apoptosis. Mol. Biol. Cell 12:2629-2645. http://dx.doi.org/10.1091/mbc.12.9.2629.
56. Hau A, Ceppi P, Peter ME. 2012. CD95 is part of a let-7/p53/miR-34 regulatory network. PLoS One 7:e49636. http://dx.doi.org/10.1371/journal.pone.0049636.
57. Kim NH, Cha YH, Kang SE, Lee Y, Lee I, Cha SY, Ryu JK, Na JM, Park C, Yoon HG, Park GJ, Yook JI, Kim HS. 2013. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle 12:1578-1587. http://dx.doi.org/10.4161/cc.24739.
58. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI. 2011. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 195:417-433. http://dx.doi.org/10.1083/jcb.201103097.
59. Siemens H, Jackstadt R, Kaller M, Hermeking H. 2013. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 4:1399-1415.
60. Sola S, Ma X, Castro RE, Kren BT, Steer CJ, Rodrigues CM. 2003. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J. Biol. Chem. 278:48831-48838. http://dx.doi.org/10.1074/jbc.M300468200.
61. Brooks CL, Gu W. 2011. The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2:456-462. http://dx.doi.org/10.1007/s13238-011-1063-9.
62. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, Vanhaecke T, Rogiers V. 2006. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug Metab. 7:629-660. http://dx.doi.org/10.2174/138920006778017759.
63. Yan F, Wang XM, Liu ZC, Pan C, Yuan SB, Ma QM. 2010. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells. Hepatobiliary Pancreat. Dis. Int. 9:287-295.
64. Wang Y, Singh R, Lefkowitch JH, Rigoli RM, Czaja MJ. 2006. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J. Biol. Chem. 281:15258-15267. http://dx.doi.org/10.1074/jbc.M512953200.
65. Takatori A, Geh E, Chen L, Zhang L, Meller J, Xia Y. 2008. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development 135:23-32. http://dx.doi.org/10.1242/dev.007120.
66. Sabapathy K. 2012. Role of the JNK pathway in human diseases. Prog. Mol. Biol. Transl. Sci. 106:145-169. http://dx.doi.org/10.1016/B978-0-12-396456-4.00013-4.
67. Czaja MJ. 2003. The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G875-G879. http://dx.doi.org/10.1152/ajpgi.00549.2002.
68. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:607-619. http://dx.doi.org/10.1101/gad.13.5.607.
69. Chen F, Hu SJ. 2012. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J. Biochem. Mol. Toxicol. 26:79-86. http://dx.doi.org/10.1002/jbt.20412.
70. Cazanave SC, Mott JL, Elmi NA, Bronk SF, Werneburg NW, Akazawa Y, Kahraman A, Garrison SP, Zambetti GP, Charlton MR, Gores GJ. 2009. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J. Biol. Chem. 284:26591-26602. http://dx.doi.org/10.1074/jbc.M109.022491.
71. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, Moura MC, Camilo ME, Rodrigues CM. 2004. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am. J. Gastroenterol. 99:1708-1717. http://dx.doi.org/10.1111/j.1572-0241.2004.40009.x.
72. Gao Z, Zhang J, Kheterpal I, Kennedy N, Davis RJ, Ye J. 2011. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J. Biol. Chem. 286:22227-22234. http://dx.doi.org/10.1074/jbc.M111.228874.
73. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333-336. http://dx.doi.org/10.1038/nature01137.